×
About 1,536 results

Fluvirin - a/singapore/gp1908/2015 ivr-180 (an a/michigan/45/2015 (h1n1)pdm09-like virus, a/hong kong/4801/2014, nymc x-263b (h3n2) (an a/hong kong/4801/2014-like virus), and b/brisbane/60/2008, wi...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d3b6dc88-d588-4cf4-97f2-3aa75b9e3e8b

Jan 3rd, 2018 - PACKAGE LABEL.PRINCIPAL DISPLAY PANEL bulk label

Gardasil 9 - human papillomavirus 9-valent vaccine, recombinant injection, suspension-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8355d971-d377-4d1d-973e-a65798bce7f9

Feb 27th, 2018 - GARDASIL 9 is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of the following diseases: Cervical, vulvar, vaginal, and anal cancer caused by Human Papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58. (1.1) Genital warts (condyloma acuminata) caused by HPV types 6 and 11. (1.1) And the following precancerous or dysplastic lesions caused by HPV types 6, ...

Prevnar 13 - pneumococcal 13-valent conjugate vaccine injection, suspension-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8c6b638-c22f-4c20-ba40-b9d5e85c9541

Feb 7th, 2018 - In children 6 weeks through 5 years of age (prior to the 6th birthday), Prevnar 13 is indicated for: active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F. (1.1) active immunization for the prevention of otitis media caused by S. pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F. No otiti...

Flublok - influenza vaccine injection, solution-Protein Sciences Corporation
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc8b76d7-97c4-4d1f-b96a-5cdb86edf40f

Jul 14th, 2016 - Flublok is a vaccine indicated for active immunization against disease caused by influenza virus subtypes A and type B contained in the vaccine. Flublok is approved for use in persons 18 years of age and older. In persons 18 through 49 years of age, this indication is based on a controlled clinical study demonstrating a decrease in influenza disease after vaccination with Flublok. In persons 50...

Flucelvax quadrivalent (prefilled syringe) - a/singapore/gp1908/2015 ivr-180 (h1n1) (an a/michigan/45/2015-like virus), a/singapore/gp2050/2015 (h3n2) (an a/hong kong/4801/2014 - like virus), b/uta...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c381cde-b850-4392-be9e-2e1ad0a3e8ef

Apr 29th, 2017 - FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FLUCELVAX QUADRIVALENT is approved for use in persons 4 years of age and older. For children and adolescents 4 through 17 years of age, approval is based on the immune response elicited by FLUCELVAX Q...

Menomune - a/c/y/w-135 combined - neisseria meningitidis group a capsular polysaccharide antigen, neisseria meningitidis group c capsular polysaccharide antigen, neisseria meningitidis group y caps...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4621a820-c776-4be5-abf5-018e45682770

Apr 12th, 2016 - Menomune® – A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Menomune – A/C/Y/W-135 vaccine is approved for use in persons 2 years of age and older. Menomune – A/C/Y/W-135 vaccine does not prevent N meningi...

Menomune - a/c/y/w-135 combined - neisseria meningitidis group a capsular polysaccharide antigen, neisseria meningitidis group c capsular polysaccharide antigen, neisseria meningitidis group y caps...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b91a360-c0d8-45ba-bf1a-836c995376bb

Apr 12th, 2016 - Menomune® – A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Menomune – A/C/Y/W-135 vaccine is approved for use in persons 2 years of age and older. Menomune – A/C/Y/W-135 vaccine does not prevent N meningi...

Ontak - denileukin diftitox injection, solution-Eisai Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42dfffb1-d0f3-42d5-944c-64f092fc436e

Jul 31st, 2011 - Ontak® is indicated for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 component of the IL-2 receptor [see Warnings and Precautions (5.4)]. Ontak is a CD25-directed cytotoxin indicated for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 component of th...

Actimmune - interferon gamma-1b injection, solution-HZNP USA, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=498b2231-65e8-4b27-947b-8d1f6f91289c

Jul 30th, 2016 - ACTIMMUNE is indicated for reducing the frequency and severity of serious infections associated with Chronic Granulomatous Disease (CGD). ACTIMMUNE is indicated for delaying time to disease progression in patients with severe, malignant osteopetrosis (SMO). ACTIMMUNE is an interferon gamma indicated for: Reducing the frequency and severity of serious infections associated with Chronic Granuloma...

Krystexxa - pegloticase injection, solution-Crealta Pharmaceuticals LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9c0d9fbb-998c-4a62-9354-7330d64b144e

Sep 14th, 2016 - KRYSTEXXA® (pegloticase) is a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Gout refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate do...

Grastek - timothy grass pollen allergen extract tablet-Merck Sharp & Dohme Corp.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1d7f3e56-c233-47a4-9bcd-80098ffff47d

Sep 14th, 2016 - GRASTEK® is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for Timothy grass or cross-reactive grass pollens. GRASTEK is approved for use in persons 5 through 65 years of age. GRASTEK is not indicated for the immediate ...

Ragwitek - short ragweed pollen allergen extract tablet-Merck Sharp & Dohme Corp.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=986abfaf-67fc-47fb-8c86-d9f9cce6fa8b

Sep 14th, 2016 - RAGWITEK® is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollen. RAGWITEK is approved for use in adults 18 through 65 years of age. RAGWITEK is not indicated for the immediate relief of al...

Panhematin - hemin injection, powder, lyophilized, for solution-RECORDATI RARE DISEASES, INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d84808a8-d039-6293-6e0d-782327f0a5c0

Jun 18th, 2017 - PANHEMATIN (hemin for injection) is indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women. Manifestations such as pain, hypertension, tachycardia, abnormal mental status and mild to progressive neurologic signs may be controlled in selected patients with this disorder. Similar findings have been reporte...

Food - animal products and poultry products, egg, white gallus sp. - egg, white gallus sp. injection, solution-Jubilant HollisterStier LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2235beb8-cf43-4f3c-8e02-598b54283f04

Jun 15th, 2017 - 20,21,22,23 Allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. The selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. The use of mixed or unrelated antigens for ski...

Food - plant source, brazil nut bertholletia excelsa - brazil nut bertholletia excelsa injection, solution-Jubilant HollisterStier LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=836a8a82-44c6-46b8-95f8-047e396e7638

Jun 15th, 2017 - 20,21,22,23 Allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. The selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. The use of mixed or unrelated antigens for ski...

Bexsero - neisseria meningitidis serogroup b nhba fusion protein antigen, neisseria meningitidis serogroup b fhbp fusion protein antigen and neisseria meningitidis serogroup b nada protein antigen ...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=380611a7-f7b6-404f-a217-a23940f8bd4a

Jan 22nd, 2015 - BEXSERO® is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals 10 through 25 years of age. Approval of BEXSERO is based on demonstration of immune response, as measured by serum bactericidal activity against three serogroup B strains representative of prevalent strains in the United Sta...

Gammagard s/d s/d - human immunoglobulin g kit-Baxalta US Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9ac2ccbf-1271-477c-9cc9-811838432506

Oct 4th, 2016 - Primary Immunodeficiency (PI) GAMMAGARD S/D is indicated for the treatment of primary immunodeficiency (PI) associated with defects in humoral immunity, in adults and children two years and older. This includes, but is not limited to, congenital agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.1,2,3 B-cell Chronic Lymphocytic...

Gammagard s/d - human immunoglobulin g kit-Baxalta US Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9ffa954-ccf0-4cfd-93f8-ddf795c62b07

Oct 4th, 2016 - Primary Immunodeficiency (PI) GAMMAGARD S/D is indicated for the treatment of primary immunodeficiency (PI) associated with defects in humoral immunity, in adults and children two years and older. This includes, but is not limited to, congenital agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.1,2,3 B-cell Chronic Lymphocytic...

Flublok quadrivalent - influenza vaccine injection, solution-Protein Sciences Corporation
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f23f0c1-6770-4f73-bd0b-0772a652bde4

Dec 11th, 2017 - Flublok Quadrivalent is a vaccine indicated for active immunization against disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Flublok Quadrivalent is approved for use in persons 18 years of age and older. (see Clinical Studies [14]) •Flublok Quadrivalent is a vaccine indicated for active immunization against disease caused by influenza A subtype viruses ...

Eculizumab injection-Food and Drug Administration
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1944fe02-2140-486a-967c-ad54bb2a479a

Dec 11th, 2017